Search Results for 'art dtg'
art dtg published presentations and documents on DocSlides.
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
10 th International Pediatric HIV Workshop
by luanne-stotts
and 22. nd. International AIDS Conference . Sele...
Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications
by liane-varnes
July 24 2018 . Overview on Safety of HIV Treatmen...
10 th International Pediatric HIV Workshop
by faustina-dinatale
and 22. nd. International AIDS Conference . Sele...
What’s New in WHO Treatment Guidelines
by aaron
July 23 2018 . What We Know About Safety Signals ...
The SA National PMTCT Guidelines (2019)
by cleminal
Outline. The ideal PMTCT pathway . Detail of new i...
Challenging Cases in Antiretroviral Therapy and Panel Discussion
by gagnon
Paul E. Sax, MD. Professor of Medicine. Harvard Me...
Updates on Individual and Universal HIV Treatment Strategies
by norah
EECA INTERACT, November 19, 2019. Stefan Baral, MD...
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents
by ethlyn
Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...
Neuropsychiatric manifestations and
by Mindbender
sleep disturbances in children and adolescents ran...
Paediatric ARV Drug Optimization 3 Review Summary report &
by neoiate
*\n\b...
Heather Watts MD Director of HIV Prevention, Program Quality Team
by alida-meadow
Heather Watts MD Director of HIV Prevention, Pro...
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.
by liane-varnes
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. ...
Potential safety issue affecting women living with HIV using
by luanne-stotts
dolutegravir. at the time of conception. Meg Doh...
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
ART in Women and Contraception: InSTIs
by olivia-moreira
ART in Women and Contraception: InSTIs , Comorbi...
HIV and Pregnancy: Current Consensus and Controversies
by elena
Jean Anderson, MD. Professor, Director of Division...
Faculty W. David Hardy, MD, AAHIVS
by christina
Scientific and Medical Consultant. Adjunct Clinica...
IAS – USA Fall New York Course: Case Discussion
by jalin
Luke . Jerram. Disclosures: Educational grant supp...
Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches
by myesha-ticknor
Clinical aspects of ADRs in HIV and ARV toxicity ...
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
by calandra-battersby
Massachusetts General Hospital. Boston, Massachus...
Interactive ART Cases From the Clinic: Is There One Right Answer?
by megan
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
CROI 2019 Scientific summary of the major clinical studies presented at CROIÂ 2019
by blanko
Résumé scientifique des principales études clin...
Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How
by taylor
Supported by an educational grant from Gilead Scie...
CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS (CROI 2020)
by miguel
AND OPPORTUNISTIC INFECTIONS. (CROI 2020). BOSTON|...